Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Sarsys AB's Sloan Ratio for the quarter that ended in Dec. 2025 was 43.19%.
As of Dec. 2025, Sarsys AB has a Sloan Ratio of 43.19%, indicating there is a warning stage of accrual build up.
Sarsys AB (NGM:SARS) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Dec. 2025, Sarsys AB has a Sloan Ratio of 43.19%, indicating there is a warning stage of accrual build up.
Sarsys AB Sloan Ratio % Related Terms
Sarsys AB Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for Sarsys AB's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGM:SARS vs COHR, KEYS, GRMN: Sloan Ratio % Comparison
For the Scientific & Technical Instruments subindustry, Sarsys AB's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sarsys AB Sloan Ratio % vs Hardware Industry
For the Hardware industry and Technology sector, Sarsys AB's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Sarsys AB's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Sarsys AB's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as
For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data.
Sarsys AB's Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was -9.409 (Jun. 2025 ) + -0.453 (Dec. 2025 ) = kr-9.86 Mil.
Sarsys AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was -19.766 (Jun. 2025 ) + -2.352 (Dec. 2025 ) = kr-22.12 Mil.
Sarsys AB's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2025 was 10.326 (Jun. 2025 ) + -10.301 (Dec. 2025 ) = kr0.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sarsys AB (NGM:SARS) has a Sloan Ratio % of 43.19% as of Dec. 2025. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Sarsys AB and its competitors.
Is Sarsys AB's Sloan Ratio % too high?
Sarsys AB's current Sloan Ratio % is 43.19%. Overall, Sarsys AB has a GF Score™ of 34/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sarsys AB's Sloan Ratio % compare to COHR and KEYS?
Sarsys AB's Sloan Ratio % of 43.19% can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Hardware company?
A good Sloan Ratio % depends on the Hardware industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Sarsys AB and its competitors. Sarsys AB's current Sloan Ratio % is 43.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sarsys AB stock overvalued right now?
Based on GuruFocus' analysis, Sarsys AB (NGM:SARS) is currently considered Fairly Valued. The stock's GF Value™ is kr0.58, compared to a current price of kr0.60 — trading 3.4% above its estimated fair value. The current Sloan Ratio % is 43.19%. Sarsys AB's overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Sarsys AB (NGM:SARS), the current Sloan Ratio % is 43.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sarsys AB (NGM:SARS) Overvalued in 2026?
Based on GuruFocus' analysis, Sarsys AB stock appears to be overvalued.
The current stock price of kr0.60 is trading 3.4% above its estimated GF Value™ of kr0.58.
GuruFocus considers Sarsys AB to be Fairly Valued.
Key valuation signals for NGM:SARS:
Sloan Ratio %: 43.19%
GF Value™: kr0.58 vs. price of kr0.60 (3.4% above fair value)
No single metric tells the full story. See the NGM:SARS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sarsys AB formerly SARSYS-ASFT AB is a developer and manufacturer of Continuous Friction Measuring Equipment and provider of cutting-edge ITS and Road/Runway Weather Information System. ASTF products include Volvo XC60/V90 Friction Tester, VW Sharan Friction, Skoda Octavia Friction, T-5 Trailer Friction, and T2GO Friction Tester. SARSYS products include Sarsys Volvo Friction Tester (V90), Sarsys Opel Friction, Sarsys Friction Tester Transporter, and Sarsys Trailer Friction Tester. The products include computerized technology for monitoring factors such as friction, freezing points, early ice warning-systems, precipitation, groundfrost, ice deposit growth, camera-surveillance systems among others.
34GF Score
Get the complete analysis for NGM:SARS
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:SARS has been successfully added to your 
